Azienda Ospedaliero-Universitaria Renato Dulbecco

Catanzaro 88100

2 studies enrolling now · 5 studies all time

What they study most

Acute Myocardial Infarction (AMI), Cardiovascular Risk, Colorectal Cancer, HER2 Amplification, HER2 Positive Solid Tumors, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, Obesity, Small Cell Lung Cancer, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — Recruiting now
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
• ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer — Running, not enrolling